SCHEMBL23725655

SCHEMBL23725655

Cc1c(CNC[C@H](C)O)nc2cc(Br)ccn2c1=O

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC1 Q13547 3/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.32
TP53 P04637 2/20 0.31
MAPT P10636 1/20 0.31
METTL3 Q86U44 1/20 0.31
NPSR1 Q6W5P4 2/20 0.31
HTT P42858 1/20 0.31
DNM1 Q05193 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
PDCD1LG2 Q9BQ51 2/20 0.30
CD274 Q9NZQ7 2/20 0.30
RXFP1 Q9HBX9 2/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23725658 1.00 POLB (0.33) POLBLMNAMAPK1SMN1; SMN2HDAC1
SCHEMBL23725934 0.84 HDAC1 (0.34) POLBHDAC1ALDH1A1KDM4ETP53
SCHEMBL30432662 0.82 ALDH1A1 (0.46) POLBLMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL23725581 0.81 GAA (0.33) POLBLMNAMAPK1SMN1; SMN2HDAC1
SCHEMBL23725667 0.78 KDM4E (0.36) POLBLMNAALDH1A1KDM4ETP53
SCHEMBL23725579 0.76 MEN1 (0.34) POLBSMN1; SMN2HDAC1ALDH1A1KDM4E
SCHEMBL25169198 0.74 PDCD1 (0.37) CD274
SCHEMBL23726614 0.74 CD274 (0.47) PDCD1LG2CD274
SCHEMBL23726613 0.74 CD274 (0.47) PDCD1LG2CD274
SCHEMBL23726231 0.70 KDM4E (0.38) POLBALDH1A1KDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL POLB 453/4885LMNA 2184/4885MAPK1 3936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.